SEC Form DEFA14A filed by Prothena Corporation plc

3/27/26 4:13:54 PM ET

$PRTA

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $PRTA alert in real time by email

DEFA14A 1 ef20069090_defa14a.htm DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant

☒

Filed by a Party other than the Registrant

☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☒	Definitive Additional Materials

☐	Soliciting Material Pursuant to § 240.14a-12

PROTHENA CORPORATION PUBLIC LIMITED COMPANY

(Name of registrant as specified in its charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V87477-P46041 PROTHENA CORPORATION PLC (THE “COMPANY”) 2026 Annual General Meeting Vote by May 13, 2026 11:59 PM ET Vote in Person at the Meeting* May 14, 2026 4:00 P.M. Local Time The Merrion Hotel Upper Merrion Street Dublin 2, D02 KF79, Ireland *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. You invested in PROTHENA CORPORATION PLC (THE “COMPANY”) and it’s time to vote! You have the right to vote on proposals being presented at the Annual General Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 14, 2026. Get informed before you vote View the Combined Notice and Proxy Statement and Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. PROTHENA CORPORATION PLC 77 SIR JOHN ROGERSON’S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2, D02 VK60, IRELAND

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V87478-P46041 1. To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company’s Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company. For Nominees: 1a. Shane M. Cooke 1b. Dennis J. Selkoe For 2. To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company’s independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company’s Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. For 3. To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company’s Proxy Statement for the Annual General Meeting. For NOTE: To transact such other business as may properly come before the Annual General Meeting. Voting Items Board Recommends

Get the next $PRTA alert in real time by email

Recent Analyst Ratings for

$PRTA

Date	Price Target	Rating	Analyst
5/28/2025	$4.00	Neutral → Underperform	BofA Securities
5/27/2025		Outperform → Perform	Oppenheimer
5/27/2025	$6.00	Buy → Hold	Jefferies
5/27/2025		Overweight → Neutral	Cantor Fitzgerald
12/20/2024	$40.00	Buy	Chardan Capital Markets
1/30/2024	$68.00 → $38.00	Buy → Neutral	BofA Securities
12/12/2023	$62.00	Buy	Deutsche Bank
4/24/2023	$80.00	Outperform	SVB Securities

More analyst ratings

SEC Form DEFA14A filed by Prothena Corporation plc

3/27/26 4:13:54 PM ET

$PRTA

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $PRTA alert in real time by email

DEFA14A 1 ef20069090_defa14a.htm DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant

☒

Filed by a Party other than the Registrant

☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☒	Definitive Additional Materials

☐	Soliciting Material Pursuant to § 240.14a-12

PROTHENA CORPORATION PUBLIC LIMITED COMPANY

(Name of registrant as specified in its charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

Get the next $PRTA alert in real time by email

Recent Analyst Ratings for

$PRTA

Date	Price Target	Rating	Analyst
5/28/2025	$4.00	Neutral → Underperform	BofA Securities
5/27/2025		Outperform → Perform	Oppenheimer
5/27/2025	$6.00	Buy → Hold	Jefferies
5/27/2025		Overweight → Neutral	Cantor Fitzgerald
12/20/2024	$40.00	Buy	Chardan Capital Markets
1/30/2024	$68.00 → $38.00	Buy → Neutral	BofA Securities
12/12/2023	$62.00	Buy	Deutsche Bank
4/24/2023	$80.00	Outperform	SVB Securities

More analyst ratings

SEC Form DEFA14A filed by Prothena Corporation plc

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PRTA

SEC Form DEFA14A filed by Prothena Corporation plc

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$PRTA

$PRTA
Analyst Ratings

Prothena downgraded by BofA Securities with a new price target

Prothena downgraded by Oppenheimer

Prothena downgraded by Jefferies with a new price target

$PRTA
Insider Purchases

Large owner Scully William P received a gift of 430,000 units of Ordinary Shares, bought $2,749,916 worth of Ordinary Shares (207,436 units at $13.26) and gifted 747,700 units of Ordinary Shares, decreasing direct ownership by 7% to 735,993 units (SEC Form 4)

$PRTA
SEC Filings